The company had posted a net profit of Rs 20.92 crore for the same period of the previous fiscal, Ipca Laboratories said in a filing to BSE.
Standalone total income from operations also rose to Rs 842.16 crore for the quarter under review, as against Rs 756.09 crore in the corresponding period last year.
While income from exports for the first quarter of this fiscal was up 17 per cent to Rs 441.23 crore, the Indian formulations income for the quarter was up 9 per cent to Rs 345.21 crore, it said.